Card image cap

Patrick Leahy's Public Statements on Issue: Drugs

1

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
05/12/2022 Letter to Hon. Chuck Schumer, Senate Majority Leader, Hon. Nancy Pelosi, Speaker of the House, Hon. Mitch McConnell, Senate Majority Leader, and Hon. Kevin McCarthy, House Minority Leader - Senator Murray Joins Bipartisan Effort to Improve Safety for Legal Cannabis Businesses  
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
12/05/2019 Letter to the Hon. Jeffrey Ragsdale, Acting Director and Chief Counsel of the Office of Professional Responsibility - Wyden And Leahy Request Ethics Investigation Of AG Barr's Approval Of Illegal DEA Mass Surveillance Program
10/29/2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
10/16/2019 Letter to the Hon. Mark Esper, Secretary of the Department of Defense - Senate Democratic Leaders Call Out Trump Administration For National Security Risks Of Diverting Anti-Taliban Funds To Border Walls
10/11/2019 Letter to K.C. Crosthwaite, CEO of Juul - Senator Hassan, Colleagues Call on Juul to End Unfair Forced Arbitration Agreements That Restrict Americans' Access to Justice
03/27/2019 Letter to the Hon. Patrick Shanahan - Senator Murray Demands Answers from Defense Department Following Transfer of $1 Billion in Military Personnel Funding to Pay for President Trump's Border Wall
03/02/2018 Letter to Aetna, AHIP, Anthem, BCBS, CareSource, Centene, Cigna, Humana, Kaiser, Molina, and UnitedHealth - Step Up Response to Opioid Epidemic
03/01/2018 Letter to Bruce D. Broussard, Chief Executive Officer & President of Humana - Feinstein, Brown, Markey Ask Health Insurers to Step Up Response to Opioid Epidemic
01/04/2018 Letter to the Hon. Gene Dodaro, Comptroller General of the Governmental Accountability Office - Kingpin Act Review
11/08/2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
11/03/2017 Letter to the Hon. Donald J. Trump, President - Support Funding to Stem Opioid Epidemic
10/25/2017 Letter to President Donald Trump - Senators Call on President to Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
10/25/2017 Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone
10/20/2017 Letter to Eric Hargan, Acting Secretary of Health and Human Services, Robert Patterson, Acting Administrator of Drug Enforcement Administration - Ensuring Patient Access and Effective Drug Enforcement Act
07/11/2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
07/11/2017 Letter to the Honorable Rex Tillerson, Secretary of State, and the Honorable Jeff Sessions, Attorney General of the United States - DEA Actions in Honduras
05/09/2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Fully Fund Office of National Drug Control Policy
03/21/2017 Letter to the Hon. Mitch McConnell - Regarding Opioid Crisis
02/23/2017 Letter to Secretary of State Rex Tillerson and Department of Homeland Security Secretary John Kelly - Reaffirm the Strategic Importance of the U.S.-Mexico Partnership
10/26/2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States - Leahy Presses Administration to Take On Opioid Distributors
08/30/2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
08/24/2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration - Account for Any Alternatives to the EpiPen Amid Product Cost Increase
07/14/2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
Page 1 of 2
arrow_upward